Market Cap 1.59B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 6,466,500
Avg Vol 5,947,018
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 85%
Beta 1.02
Analysts Strong Sell
Price Target $10.43

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
bonecrack_benny
bonecrack_benny May. 26 at 12:56 PM
0 · Reply
tradersunion353
tradersunion353 May. 26 at 12:48 PM
$ABCL 5 years overhyped junk is down by 83% down by 30% on phase 1 data expecting phase 2 irrespetive of outcome stock wont make move then what are these married to ABCL clowns celebrating for??
1 · Reply
Ckkung71
Ckkung71 May. 26 at 12:45 PM
$ABCL Today it will be interesting if they try ⤵️ or if they have run out of power..
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 26 at 3:42 AM
$ABCL RSI: 58.50, MACD: 0.2179 Vol: 0.45, MA20: 4.58, MA50: 3.99 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
snowPOW
snowPOW May. 25 at 11:20 PM
$ABCL Good stuff here.
0 · Reply
tradersunion353
tradersunion353 May. 25 at 10:34 PM
$ABCL lots of fake longs overhyped junk without delivery any real value for real investors..
1 · Reply
Stocktradesmoon
Stocktradesmoon May. 25 at 8:28 PM
$ABCL I have $ABCL fomo and I’m afraid it just gaps up hard this week and none of you get an entry. Might add pre market tonight.
1 · Reply
Stocktradesmoon
Stocktradesmoon May. 25 at 8:11 PM
$ABCL Destined for greatness. Look at that volume…
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 25 at 6:23 PM
$ABCL Went from 9.5% to 14.79% this morning. It’s getting into painful territory for shorts, and if the price keeps going up, the 44m+ short interest (on a shrinking float, if institutions are taking positions) are going to be in real trouble. Very interesting!
0 · Reply
Stockingtrade
Stockingtrade May. 25 at 2:07 PM
$ABCL Borrow rate is now 14.79% - shorts getting squeezed!!!
1 · Reply
Latest News on ABCL
AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 14 days ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Q1 Earnings Call Highlights

May 11, 2026, 7:08 PM EDT - 14 days ago

AbCellera Biologics Q1 Earnings Call Highlights


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 14 days ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 14 days ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 14 days ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 14 days ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 21 days ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 27 days ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 27 days ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 6 weeks ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 3 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 3 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 4 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 7 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 7 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera appoints Sarah Noonberg as Chief Medical Officer

2025-09-10T13:20:54.000Z - 9 months ago

AbCellera appoints Sarah Noonberg as Chief Medical Officer

MGX


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 9 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera doses first participants in Phase 1 trial of ABCL575

2025-08-27T13:20:26.000Z - 9 months ago

AbCellera doses first participants in Phase 1 trial of ABCL575


AbCellera price target raised to $7 from $5 at BMO Capital

2025-08-08T13:26:29.000Z - 10 months ago

AbCellera price target raised to $7 from $5 at BMO Capital


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 10 months ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera assumed with an Outperform at Leerink

2025-07-07T10:40:33.000Z - 11 months ago

AbCellera assumed with an Outperform at Leerink


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


bonecrack_benny
bonecrack_benny May. 26 at 12:56 PM
0 · Reply
tradersunion353
tradersunion353 May. 26 at 12:48 PM
$ABCL 5 years overhyped junk is down by 83% down by 30% on phase 1 data expecting phase 2 irrespetive of outcome stock wont make move then what are these married to ABCL clowns celebrating for??
1 · Reply
Ckkung71
Ckkung71 May. 26 at 12:45 PM
$ABCL Today it will be interesting if they try ⤵️ or if they have run out of power..
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 26 at 3:42 AM
$ABCL RSI: 58.50, MACD: 0.2179 Vol: 0.45, MA20: 4.58, MA50: 3.99 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
snowPOW
snowPOW May. 25 at 11:20 PM
$ABCL Good stuff here.
0 · Reply
tradersunion353
tradersunion353 May. 25 at 10:34 PM
$ABCL lots of fake longs overhyped junk without delivery any real value for real investors..
1 · Reply
Stocktradesmoon
Stocktradesmoon May. 25 at 8:28 PM
$ABCL I have $ABCL fomo and I’m afraid it just gaps up hard this week and none of you get an entry. Might add pre market tonight.
1 · Reply
Stocktradesmoon
Stocktradesmoon May. 25 at 8:11 PM
$ABCL Destined for greatness. Look at that volume…
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 25 at 6:23 PM
$ABCL Went from 9.5% to 14.79% this morning. It’s getting into painful territory for shorts, and if the price keeps going up, the 44m+ short interest (on a shrinking float, if institutions are taking positions) are going to be in real trouble. Very interesting!
0 · Reply
Stockingtrade
Stockingtrade May. 25 at 2:07 PM
$ABCL Borrow rate is now 14.79% - shorts getting squeezed!!!
1 · Reply
Estimize
Estimize May. 25 at 11:09 AM
Wall St is expecting -0.14 EPS for $ABCL Q2 [Reporting 08/06 AMC] http://www.estimize.com/intro/abcl?chart=historical&metric_name=eps&utm_c
0 · Reply
tradersunion353
tradersunion353 May. 25 at 1:22 AM
$ABCL overhyped junkie new script from few married to ABCL folks ” we no longer care if stock drops after phase 2 data” we love this company these clowns should stop trading ASAP especially one one paid artist called jack prescott - this guy has beeb pump this scam left and right
1 · Reply
PolarBear1
PolarBear1 May. 24 at 9:15 PM
$ABCL https://www.pnas.org/doi/10.1073/pnas.1211517109
0 · Reply
PolarBear1
PolarBear1 May. 24 at 9:08 PM
$ABCL https://www.reddit.com/r/ABCL/comments/1sp5uln/why_abcls_abcl635_phase_2_readouts_will_be/ https://www.reddit.com/r/ABCL/comments/1tdjpst/why_abcl635_has_a_strong_chance_of_positive_phase/
0 · Reply
PhotonicDigger
PhotonicDigger May. 24 at 4:22 PM
$ABCL remains in a key technical phase with the 200WMA acting as an expected resistance zone, consistent with prior wave structure behavior. A sustained move above $5.30 would shift focus toward higher resistance near $6.50, with a potential extension into a broader upside range if momentum continues. Trend continuation depends on reclaiming key moving average levels and confirming breakout structure.
0 · Reply
Ckkung71
Ckkung71 May. 24 at 12:32 PM
$ABCL Positions advertised so far in May 2026: • QA Operations Manager (Vancouver) • Manager, QC Systems (×2) • Specialist, QC Systems (×2) • In Vivo Specialist, Operations (Vancouver) • In Vivo Specialist, Research (Vancouver) • Gestionnaire des études cliniques internationales (Montreal)
0 · Reply
PolarBear1
PolarBear1 May. 23 at 5:33 AM
1 · Reply
Tahadicaprio
Tahadicaprio May. 23 at 12:59 AM
0 · Reply
Tahadicaprio
Tahadicaprio May. 23 at 12:49 AM
━━━━━━━━━━━━━━ 📈 NEXT WEEK WATCHLIST ━━━━━━━━━━━━━━ 🥇 $IBRX – 8.40$ 🥈 $ABCL – 6.20$ 🥉 $NNOX –2.07$ 🎰 $QNTM –12$ ⚠️ $TE –11$
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 22 at 11:11 PM
$ABCL I am reminded of the phrase “Can’t see the forest for the trees”. I’m invested in what I believe will be golden egg laying goose. Not a single molecule.
0 · Reply
Cassek86
Cassek86 May. 22 at 11:06 PM
$ABCL You really have too much time on your hands, don't you? Get a hobby.
1 · Reply
Stocktradesmoon
Stocktradesmoon May. 22 at 11:00 PM
$ABCL Carl Hansen profile pictures now… LFG 🤣👍🏻
0 · Reply